Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12 participants
OBSERVATIONAL
2016-04-30
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Involvement in Dystrophinopathies Part 2
NCT04668716
Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2
NCT05854433
Myotonic Dystrophy - Vascular and Cognition
NCT04656210
Tracking the Brain in Myotonic Dystrophies: a 5-year Longitudinal Follow-up Study
NCT02729597
Functional MRI Biomarkers of Cognitive Decrements in Diabetes
NCT01705210
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with LGMD2N
Five patients over 18 years old with genetically verified LGMD2N
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sofie Thurø Østergaard
Scholarship student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sofie T. Østergaard, Bsc.
Role: PRINCIPAL_INVESTIGATOR
Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, Copenhagen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Copenhagen Neuromuscular Center, Rigshospitalet
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ostergaard ST, Johnson K, Stojkovic T, Krag T, De Ridder W, De Jonghe P, Baets J, Claeys KG, Fernandez-Torron R, Phillips L, Topf A, Colomer J, Nafissi S, Jamal-Omidi S, Bouchet-Seraphin C, Leturcq F, MacArthur DG, Lek M, Xu L, Nelson I, Straub V, Vissing J. Limb girdle muscular dystrophy due to mutations in POMT2. J Neurol Neurosurg Psychiatry. 2018 May;89(5):506-512. doi: 10.1136/jnnp-2017-317018. Epub 2017 Nov 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STO-POMT2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.